The modules will help educate neonatal healthcare professionals in neonatal drug development, pipeline decision-making and addressing neonate needs in the current environment.  Continue reading→

Five new divisions created to address agency goalsContinue reading→

Two Technologies Combine to deliver unrivaled Facial Skin RejuvenationContinue reading→

Medical Devices; Laboratory Developed Tests, a rule by the Food and Drug Administration was published on the Federal Register on 05/06/2024.  The rule is effective  July 5, 2024.Continue reading→

Implant Marks Over 2080 Total SynCardia Total Artificial Heart CasesContinue reading→

This week, the FDA released its long-awaited final rule on the regulation of laboratory-developed tests (LDTs). 

Along with the rule, the agency published drafts of two guidance documents covering its enforcement policy for LDTs that are created “for immediate response to an emergent situation, such as an outbreak of an infectious disease.” One document covers enforcement when a public-health emergency hasn’t yet been declared; the other covers enforcement once the nation is in an official public-health emergency. Continue reading→

PHOENIX (May 1, 2024) – CommonSpirit Health, the parent organization of Dignity Health, has named Anthony Houston, EdD, FACHE, president of its Arizona market. The organization’s Arizona market comprises eight acute care hospitals, a medical group, graduate medical education programs, imaging centers, specialty hospitals, urgent cares, freestanding emergency departments, insurance providers, an accountable care organization and other clinical partnerships. Houston will begin his duties this summer. Continue reading→

By Alexander Diegel

Layne Oliff was an active runner who successfully completed 10-mile trail runs up until his 60th birthday — before he was diagnosed with amyotrophic lateral sclerosis (ALS) in November of 2020. Layne soon pivoted that same drive and commitment to another journey, as an active advocate in the ALS community.Continue reading→

Extending Beyond Brain Tumors, Empowering Patients with Treatment Options in Prostate Cancer and Other MalignanciesContinue reading→